ObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11 – 12, 2020

Rhea-AI Summary

ObsEva SA (NASDAQ: OBSV) announced that CEO Ernest Loumaye will present an update on the company’s pipeline at the Wedbush PacGrow Virtual Healthcare Conference on August 12, 2020, at 9:45 a.m. ET. Investors can access a live presentation link via the Events Calendar on ObsEva’s website. ObsEva is focused on innovative therapies for women’s reproductive health, including treatments for endometriosis, uterine fibroids, and preterm labor. The company is also traded on the SIX Swiss Exchange under the ticker “OBSN”.

News Market Reaction – OBSV

-1.12%

-1.12% Session move

In the trading session that priced this news, OBSV declined 1.12%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

 

Geneva, Switzerland and Boston, MA –  August 7, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that CEO Ernest Loumaye will present an update on the Company and its pipeline at the Wedbush PacGrow Virtual Healthcare Conference taking place August 11 - 12, 2020.

Mr. Loumaye’s presentation will take place on Wednesday August 12, 2020 at 9:45 a.m. Eastern Time (ET).  A live presentation link will be available under “Events Calendar” in the investors section of ObsEva’s website at www.ObsEva.com

 

About ObsEva

ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor, and improving ET outcomes following IVF. ObsEva is listed on the Nasdaq Global Select Market and is trading under the ticker symbol "OBSV" and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.

 

For further information, please contact:

 

CEO Office contact
Shauna Dillon
Shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact
Mario Corso
Vice President, Investor Relations
mario.corso@obseva.com

+1 857 972 9347 Office
+1 781 366 5726 Mobile

 

Attachment

• Press Release in Pdf

FAQ

What is the date of ObsEva's presentation at the Wedbush PacGrow Virtual Healthcare Conference?

ObsEva's presentation will take place on August 12, 2020.

What time will ObsEva's CEO present at the conference?

CEO Ernest Loumaye will present at 9:45 a.m. Eastern Time (ET).

Where can I watch ObsEva's live presentation?

The live presentation can be accessed under the Events Calendar on ObsEva’s website.

What is the focus of ObsEva's clinical pipeline?

ObsEva's pipeline focuses on therapies for women's reproductive health, including endometriosis and uterine fibroids.

Under what ticker is ObsEva traded on NASDAQ?

ObsEva is traded under the ticker symbol 'OBSV' on NASDAQ.